EDGAR Filing Documents for 0001213900-20-015132

Form 8-K - Current report:

SEC Accession No. 0001213900-20-015132

Filing Date

2020-06-17

Accepted

2020-06-16 19:13:08

Documents

Period of Report

2020-06-11

Items

Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea123112-8k_lanternpharma.htm	8-K	21177
2	AMENDMENT TO CERTIFICATE OF INCORPORATION	ea123112ex3-1iv_lantern.htm	EX-3.1.IV	1963
3	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION	ea123112ex3-1v_lantern.htm	EX-3.1.V	4178
4	PRESS RELEASE ANNOUNCING THE CLOSING OF THE INITIAL PUBLIC OFFERING	ea123112ex99-1_lantern.htm	EX-99.1	9151
5	GRAPHIC	ex99-1_001.jpg	GRAPHIC	14703
6	GRAPHIC	ex3-1iv_001.jpg	GRAPHIC	114827
7	GRAPHIC	ex3-1iv_002.jpg	GRAPHIC	313910
8	GRAPHIC	ex3-1iv_003.jpg	GRAPHIC	65150
9	GRAPHIC	ex3-1v_001.jpg	GRAPHIC	112144
10	GRAPHIC	ex3-1v_002.jpg	GRAPHIC	235217
11	GRAPHIC	ex3-1v_003.jpg	GRAPHIC	428398
12	GRAPHIC	ex3-1v_004.jpg	GRAPHIC	380207
13	GRAPHIC	ex3-1v_005.jpg	GRAPHIC	384080
14	GRAPHIC	ex3-1v_006.jpg	GRAPHIC	173925
15	GRAPHIC	ex3-1v_007.jpg	GRAPHIC	96316
	Complete submission text file	0001213900-20-015132.txt		3231595

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201

Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136

Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)